865 related articles for article (PubMed ID: 31023030)
61. Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
Koinis F; Vetsika EK; Aggouraki D; Skalidaki E; Koutoulaki A; Gkioulmpasani M; Georgoulias V; Kotsakis A
J Thorac Oncol; 2016 Aug; 11(8):1263-1272. PubMed ID: 27178984
[TBL] [Abstract][Full Text] [Related]
62. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
Bayik D; Lee J; Lathia JD
Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
[TBL] [Abstract][Full Text] [Related]
63. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
[TBL] [Abstract][Full Text] [Related]
64. Circulating Levels of Monocytic Myeloid-Derived Suppressor Cells (M-MDSC) and CXCL-8 in Non-Small Cell Lung Cancer (NSCLC).
Zadian SS; Adcock IM; Salimi B; Mortaz E
Tanaffos; 2021 Jan; 20(1):15-21. PubMed ID: 34394365
[TBL] [Abstract][Full Text] [Related]
65. S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma.
Huang M; Wu R; Chen L; Peng Q; Li S; Zhang Y; Zhou L; Duan L
Front Immunol; 2019; 10():2243. PubMed ID: 31620141
[TBL] [Abstract][Full Text] [Related]
66. Monocytic myeloid-derived suppressor cells as an immune indicator of early diagnosis and prognosis in patients with sepsis.
Cui J; Cai W; Lin J; Zhang L; Miao Y; Xu Y; Zhao W
BMC Infect Dis; 2024 Apr; 24(1):399. PubMed ID: 38609858
[TBL] [Abstract][Full Text] [Related]
67. Monocytic MDSC as a source of immunosuppressive cytokines in chronic lymphocytic leukemia (CLL) microenvironment.
Kowalska W; Bojarska-Junak A
Folia Histochem Cytobiol; 2020; 58(1):25-36. PubMed ID: 32227331
[TBL] [Abstract][Full Text] [Related]
68. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer.
Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J
Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434
[TBL] [Abstract][Full Text] [Related]
69. Characterization of the myeloid-derived suppressor cell subset regulated by NK cells in malignant lymphoma.
Sato Y; Shimizu K; Shinga J; Hidaka M; Kawano F; Kakimi K; Yamasaki S; Asakura M; Fujii SI
Oncoimmunology; 2015 Mar; 4(3):e995541. PubMed ID: 25949922
[TBL] [Abstract][Full Text] [Related]
70. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
71. Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia.
Wang H; Tao Q; Wang Z; Zhang Q; Xiao H; Zhou M; Dong Y; Zhai Z
J Immunol Res; 2020; 2020():7363084. PubMed ID: 33415170
[TBL] [Abstract][Full Text] [Related]
72. Endoplasmic reticulum stress induced LOX-1
Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
[TBL] [Abstract][Full Text] [Related]
73. MDSC subtypes and CD39 expression on CD8
Koh J; Kim Y; Lee KY; Hur JY; Kim MS; Kim B; Cho HJ; Lee YC; Bae YH; Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Eur J Immunol; 2020 Nov; 50(11):1810-1819. PubMed ID: 32510574
[TBL] [Abstract][Full Text] [Related]
74. Human myeloid-derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data.
De Zuani M; Hortová-Kohoutková M; Andrejčinová I; Tomášková V; Šrámek V; Helán M; Frič J
Eur J Immunol; 2021 Jul; 51(7):1785-1791. PubMed ID: 33788255
[TBL] [Abstract][Full Text] [Related]
75. Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator.
Oliver L; Alvarez R; Diaz R; Valdés A; Colligan SH; Nemeth MJ; Twum DYF; Fernández A; Fernández-Medina O; Carlson LM; Yu H; Eng KH; Hensen ML; Rábade-Chediak ML; Fernández LE; Lee KP; Perez L; Muhitch JB; Mesa C; Abrams SI
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36150744
[TBL] [Abstract][Full Text] [Related]
76. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
[TBL] [Abstract][Full Text] [Related]
77. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
[TBL] [Abstract][Full Text] [Related]
78. Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.
Bruderek K; Schirrmann R; Brandau S
Methods Mol Biol; 2021; 2236():1-7. PubMed ID: 33237535
[TBL] [Abstract][Full Text] [Related]
79. Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.
Cassetta L; Bruderek K; Skrzeczynska-Moncznik J; Osiecka O; Hu X; Rundgren IM; Lin A; Santegoets K; Horzum U; Godinho-Santos A; Zelinskyy G; Garcia-Tellez T; Bjelica S; Taciak B; Kittang AO; Höing B; Lang S; Dixon M; Müller V; Utikal JS; Karakoç D; Yilmaz KB; Górka E; Bodnar L; Anastasiou OE; Bourgeois C; Badura R; Kapinska-Mrowiecka M; Gotic M; Ter Laan M; Kers-Rebel E; Król M; Santibañez JF; Müller-Trutwin M; Dittmer U; de Sousa AE; Esendağlı G; Adema G; Loré K; Ersvær E; Umansky V; Pollard JW; Cichy J; Brandau S
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32907925
[TBL] [Abstract][Full Text] [Related]
80. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
